The interaction between two proteins associated with a glutamate receptor can drive neuronal death mediated through this receptor after stroke. A small molecule, designed to specifically disrupt this deadly interaction, protects the brain in mice and rats against neuronal damage without undesirable side effects (pages 1439–1443).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Biochemical investigations of the mechanism of action of small molecules ZL006 and IC87201 as potential inhibitors of the nNOS-PDZ/PSD-95-PDZ interactions
Scientific Reports Open Access 16 July 2015
-
Promising targets of cell death signaling of NR2B receptor subunit in stroke pathogenesis
Regenerative Medicine Research Open Access 23 July 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Choi, D.W. & Rothman, S.M. Annu. Rev. Neurosci. 13, 171–182 (1990).
De Keyser, J. et al. Trends Neurosci. 22, 535–540 (1999).
Martin, H.G. & Wang, Y.T. Cell 140, 174–176 (2010).
Aarts, M. et al. Science 298, 846–850 (2002).
Taghibiglou, C. et al. Nat. Med. 15, 1399–1406 (2009).
Tu, W. et al. Cell 140, 222–234 (2010).
Vlieghe, P., Lisowski, V., Martinez, J. & Khrestchatisky, M. Drug Discov. Today 15, 40–56 (2010).
Zhou, L. et al. Nat. Med. 16, 1439–1443 (2010).
Monyer, H. et al. Science 256, 1217–1221 (1992).
Christopherson, K.S., Hillier, B.J., Lim, W.A. & Bredt, D.S. J. Biol. Chem. 274, 27467–27473 (1999).
Sattler, R. et al. Science 284, 1845–1848 (1999).
Florio, S.K. et al. Br. J. Pharmacol. 158, 494–506 (2009).
Tochio, H. et al. J. Mol. Biol. 303, 359–370 (2000).
Zorumski, C.F. & Izumi, Y. Prog. Brain Res. 118, 173–182 (1998).
Fan, J., Cowan, C.M., Zhang, L.Y., Hayden, M.R. & Raymond, L.A. J. Neurosci. 29, 10928–10938 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Lai, T., Wang, Y. Fashioning drugs for stroke. Nat Med 16, 1376–1378 (2010). https://doi.org/10.1038/nm1210-1376
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1210-1376
This article is cited by
-
Prolonged Use of NMDAR Antagonist Develops Analgesic Tolerance in Neuropathic Pain via Nitric Oxide Reduction-Induced GABAergic Disinhibition
Neurotherapeutics (2020)
-
The Role of GluN2A in Cerebral Ischemia: Promoting Neuron Death and Survival in the Early Stage and Thereafter
Molecular Neurobiology (2018)
-
Pathogenic mechanisms following ischemic stroke
Neurological Sciences (2017)
-
Neuroprotective strategies for NMDAR-mediated excitotoxicity in Huntington’s Disease
Frontiers in Biology (2016)
-
Biochemical investigations of the mechanism of action of small molecules ZL006 and IC87201 as potential inhibitors of the nNOS-PDZ/PSD-95-PDZ interactions
Scientific Reports (2015)